December 14, 2011
Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias
December 13, 2011
Threshold Pharmaceuticals Announces Update to TH-302 Pancreatic Data to Be Presented at the Oppenheimer Healthcare Conference
November 29, 2011
Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
 |
